Investigation of novel target genes regulated by polycomb group genes in hepatocellular carcinoma
多梳族基因调控的肝细胞癌新靶基因研究
基本信息
- 批准号:21790649
- 负责人:
- 金额:$ 2.75万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Young Scientists (B)
- 财政年份:2009
- 资助国家:日本
- 起止时间:2009 至 2010
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
PcG proteins form chromatin-associated multiprotein complexes, polycomb repressive complex 1 (PRC1) and PRC2 and repress the expression of targets such as Ink4a/Arf genes. Bmi1, a component of PRC1, has been implicated in the regulation of self-renewal in a range of different stem cells including hepatic stem cells. Analyses of Bmi1-deficient and/or Ink4a/Arf-deficient hepatic stem cells revealed that Bmi1 regulates self-renewal and tumorigenicity in both Ink4a/Arf-dependent and -independent manners. Microarray analyses successfully identified 5 down-regulated genes as candidate downstream targets for Bmi1 such as sex determining region Y-box 17 (Sox17).Loss-of-function assays of Ezh2, a major component of PRC2, also revealed that Ezh2 tightly regulates self-renewal in both normal and cancer stem cells in liver. Moreover, we showed that pharmacological inhibition of EZH2 by an S-adenosylhomocysteine hydrolase inhibitor, 3-deazaneplanocin A (DZNep) is a promising approach for the eradication of liver cancer stem cells.
PcG蛋白形成染色质相关的多蛋白复合物,多梳抑制复合物1(PRC 1)和PRC 2,并抑制靶基因如Ink 4a/Arf基因的表达。Bmi 1是PRC 1的一个组成部分,参与了包括肝干细胞在内的一系列不同干细胞自我更新的调节。对Bmi 1缺陷型和/或Ink 4a/Arf缺陷型肝干细胞的分析表明,Bmi 1以Ink 4a/Arf依赖和非依赖的方式调节自我更新和致瘤性。基因芯片分析成功鉴定了5个下调基因作为Bmi 1的候选下游靶点,如性别决定区Y-box 17(Sox 17)。Ezh 2是PRC 2的主要成分,其功能丧失分析也显示Ezh 2在肝脏正常和癌症干细胞中密切调节自我更新。此外,我们表明,药理学抑制EZH 2的S-腺苷高半胱氨酸水解酶抑制剂,3-deazaneplanocin A(DZNep)是一种有前途的方法,用于根除肝癌干细胞。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
The polycomb group gene product Ezh2 regulates proliferation and differentiation of murine hepatic stem/progenitor cells
- DOI:10.1016/j.jhep.2010.01.027
- 发表时间:2010-06-01
- 期刊:
- 影响因子:25.7
- 作者:Aoki, Ryutaro;Chiba, Tetsuhiro;Iwama, Atsushi
- 通讯作者:Iwama, Atsushi
Regulation of liver cancer stem cells by polycomb group proteins.
多梳族蛋白对肝癌干细胞的调节。
- DOI:
- 发表时间:2011
- 期刊:
- 影响因子:0
- 作者:千葉哲博;岩間厚志;横須賀収
- 通讯作者:横須賀収
Regulatory machinery of Bmil in both normal and cancer stem cells in liver
Bmil 在肝脏正常干细胞和癌症干细胞中的调节机制
- DOI:
- 发表时间:2009
- 期刊:
- 影响因子:0
- 作者:千葉哲博;青木竜太郎;横須賀収;岩間厚志
- 通讯作者:岩間厚志
Dmapl plays an essential role in the maintenance of genome integrity through the DNA repair process
Dmapl 通过 DNA 修复过程在维持基因组完整性方面发挥着重要作用
- DOI:
- 发表时间:2009
- 期刊:
- 影响因子:0
- 作者:Negishi M;et al.
- 通讯作者:et al.
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
CHIBA Tetsuhiro其他文献
CHIBA Tetsuhiro的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('CHIBA Tetsuhiro', 18)}}的其他基金
Epigenetic regulation of liver cancer stem cells and establishment of a novel therapeutic approach
肝癌干细胞的表观遗传调控及新治疗方法的建立
- 批准号:
23689039 - 财政年份:2011
- 资助金额:
$ 2.75万 - 项目类别:
Grant-in-Aid for Young Scientists (A)
Investigation of cancer stem cell system in hepatocellular carcinoma
肝癌干细胞系统的研究
- 批准号:
19790468 - 财政年份:2007
- 资助金额:
$ 2.75万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
相似海外基金
B型肝炎ウイルスのゲノム組み込みは染色体外DNAを発生させて肝臓癌を導くか?
乙型肝炎病毒基因组整合会产生染色体外DNA并导致肝癌吗?
- 批准号:
24K18935 - 财政年份:2024
- 资助金额:
$ 2.75万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
キサンチン酸化還元酵素 (XOR)を標的とした脂肪肝炎/肝臓癌診断のバイオマーカー開発
针对黄嘌呤氧化还原酶 (XOR) 的脂肪性肝炎/肝癌诊断生物标志物开发
- 批准号:
24K13447 - 财政年份:2024
- 资助金额:
$ 2.75万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Quantitative ultrasound to improve detection and diagnosis of liver cancer
定量超声改善肝癌的检测和诊断
- 批准号:
490038 - 财政年份:2023
- 资助金额:
$ 2.75万 - 项目类别:
Operating Grants
Modulating the immuno-metabolic interplay in liver cancer with cryoablation
通过冷冻消融调节肝癌的免疫代谢相互作用
- 批准号:
10647494 - 财政年份:2023
- 资助金额:
$ 2.75万 - 项目类别:
In vivo feasibility of a smart needle ablation treatment for liver cancer
智能针消融治疗肝癌的体内可行性
- 批准号:
10699190 - 财政年份:2023
- 资助金额:
$ 2.75万 - 项目类别:
TUMOUR-HOST INTERACTIONS IN LIVER CANCER OF CHILDHOOD AND ADULTS
儿童和成人肝癌中肿瘤与宿主的相互作用
- 批准号:
10100127 - 财政年份:2023
- 资助金额:
$ 2.75万 - 项目类别:
EU-Funded
Engineering and preliminary safety assessment of an RNA trans-splicing therapeutic vector for liver cancer.
肝癌 RNA 反式剪接治疗载体的工程设计和初步安全性评估。
- 批准号:
10075525 - 财政年份:2023
- 资助金额:
$ 2.75万 - 项目类别:
Grant for R&D
Development of all-round combination immunotherapy for advanced liver cancer
晚期肝癌全方位联合免疫疗法的研发
- 批准号:
23H02886 - 财政年份:2023
- 资助金额:
$ 2.75万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Modelling cargo loaded macrophage trafficking across liver endothelium: a new approach to drug delivery in liver cancer.
模拟负载巨噬细胞穿过肝内皮的运输:肝癌药物输送的新方法。
- 批准号:
2890431 - 财政年份:2023
- 资助金额:
$ 2.75万 - 项目类别:
Studentship
Novel circulating biomarker digital scores for assessing treatment response in liver cancer
用于评估肝癌治疗反应的新型循环生物标志物数字评分
- 批准号:
10651050 - 财政年份:2023
- 资助金额:
$ 2.75万 - 项目类别: